129 related articles for article (PubMed ID: 27432265)
1. Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population.
Tan T; Zhang K; Chen W
Breast Cancer; 2017 May; 24(3):369-374. PubMed ID: 27432265
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.
Rudolph A; Fasching PA; Behrens S; Eilber U; Bolla MK; Wang Q; Thompson D; Czene K; Brand JS; Li J; Scott C; Pankratz VS; Brandt K; Hallberg E; Olson JE; Lee A; Beckmann MW; Ekici AB; Haeberle L; Maskarinec G; Le Marchand L; Schumacher F; Milne RL; Knight JA; Apicella C; Southey MC; Kapuscinski MK; Hopper JL; Andrulis IL; Giles GG; Haiman CA; Khaw KT; Luben R; Hall P; Pharoah PD; Couch FJ; Easton DF; Dos-Santos-Silva I; Vachon C; Chang-Claude J
Breast Cancer Res; 2015 Aug; 17(1):110. PubMed ID: 26275715
[TBL] [Abstract][Full Text] [Related]
3. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.
Wang C; Zhao H; Zhao X; Wan J; Wang D; Bi W; Jiang X; Gao Y
Tumour Biol; 2014 Jan; 35(1):295-301. PubMed ID: 23918301
[TBL] [Abstract][Full Text] [Related]
4. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women.
Pan Z; Fu Z; Song Q; Cao W; Cheng W; Xu X
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323034
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population.
Li J; Wang Y; Zhu Y; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Ke J; Gong J; Zhong R; Chang J
Carcinogenesis; 2017 Apr; 38(4):447-454. PubMed ID: 28334234
[TBL] [Abstract][Full Text] [Related]
7. Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population.
Yang W; He X; He C; Peng L; Xing S; Li D; Wang L; Jin T; Yuan D
Clin Breast Cancer; 2021 Jun; 21(3):e235-e242. PubMed ID: 33281037
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.
Wang Y; He Y; Qin Z; Jiang Y; Jin G; Ma H; Dai J; Chen J; Hu Z; Guan X; Shen H
Breast Cancer Res; 2014 Aug; 16(4):422. PubMed ID: 25116933
[TBL] [Abstract][Full Text] [Related]
9. The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer.
Wang J; Shi Y; Wang G; Dong S; Yang D; Zuo X
Mol Genet Genomic Med; 2019 Aug; 7(8):e804. PubMed ID: 31297985
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population.
Xia P; Jin T; Geng T; Sun T; Li X; Dang C; Kang L; Chen C; Sun J
Tumour Biol; 2014 Mar; 35(3):2187-90. PubMed ID: 24127041
[TBL] [Abstract][Full Text] [Related]
11. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
[TBL] [Abstract][Full Text] [Related]
12. Predictive polymorphisms for breast cancer in postmenopausal Mexican women.
Sierra-Martinez M; Hernández-Cadena L; García-Sánchez JR; Acosta-Altamirano G; Palacios-Reyes C; Alonso-Themann PG; García-Ortiz L; Quintas-Granados LI; Reyes-Hernández OD
J Cancer Res Ther; 2018; 14(3):640-646. PubMed ID: 29893332
[TBL] [Abstract][Full Text] [Related]
13. The association between a novel polymorphism (rs1062577) in ESR1 and breast cancer susceptibility in the Han Chinese women.
Chen L; Kang H; Jin GJ; Chen X; Zhang QY; Lao WT; Li R
Gynecol Endocrinol; 2016 Jul; 32(7):553-6. PubMed ID: 26850117
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in ultraconserved elements and risk of breast cancer in Chinese population.
Shen H; Lu C; Jiang Y; Tang J; Chen W; Zhang H; Zhang Q; Wang J; Liang J; Hu Z; Shen H
Breast Cancer Res Treat; 2011 Aug; 128(3):855-61. PubMed ID: 21331621
[TBL] [Abstract][Full Text] [Related]
15. Diverse associations between ESR1 polymorphism and breast cancer development and progression.
Ding SL; Yu JC; Chen ST; Hsu GC; Hsu HM; Ho JY; Lin YH; Chang CC; Fann CS; Cheng CW; Wu PE; Shen CY
Clin Cancer Res; 2010 Jul; 16(13):3473-84. PubMed ID: 20570923
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
17. Association of rs2234693 and rs9340799 polymorphisms of ESR1 gene in breast cancer of Mexican population.
Carrillo-Moreno DI; Eduardo Figuera L; Zuniga González GM; Puebla Perez AM; Jesus Moran Mendoza A; Gallegos Arreola MP
J BUON; 2019; 24(5):1927-1933. PubMed ID: 31786857
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of FOXP1 and FOXF1 are associated with the susceptibility of oesophageal adenocarcinoma in Chinese population.
Zhang J; Chen J; Ma T; Guo H; Yang B
J Genet; 2018 Mar; 97(1):213-218. PubMed ID: 29666340
[TBL] [Abstract][Full Text] [Related]
19. Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.
Rezende LM; Marson FA; Lima CS; Bertuzzo CS
Gene; 2017 Apr; 608():73-78. PubMed ID: 28109853
[TBL] [Abstract][Full Text] [Related]
20. Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer.
Jeon S; Choi JY; Lee KM; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2010 Jun; 121(3):737-42. PubMed ID: 19941161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
